Merck & (MRK) Revenue — Quarter Ended Mar 31, 2025
Revenue for the quarter decreased compared to both the immediately preceding quarter and the same quarter one year earlier. The decline was modest but continued a trend of sequential decreases from the prior year's peak.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the quarter decreased compared to both the immediately preceding quarter and the same quarter one year earlier. The decline was modest but continued a trend of sequential decreases from the prior year's peak.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15.5B
Revenue reported for this quarter.
Quarter-over-quarter
-0.6%
Change from the immediately preceding quarter.
Year-over-year
-1.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$63.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $16.1B | +7.2% |
| Sep 30, 2024 | $16.7B | +4.4% |
| Dec 31, 2024 | $15.6B | +6.8% |
| Mar 31, 2025 | $15.5B | -1.6% |
Revenue performance
The reported revenue moved lower, reflecting a slight contraction from the previous quarter and a more notable drop from the same period last year.
Quarterly comparison
When measured against the prior quarter, revenue edged down, and the year-over-year comparison also showed a decline. This marks the third consecutive quarter of sequential revenue reduction.
What to watch
The company's operating cash flow was reduced by milestone payments, which may influence future investment in revenue-generating initiatives.